http://www.prescriber.co.uk Prescriber EarlyView RSS Feed http://www.prescriber.co.uk/details/journalArticle/1456857/Recommended_drug_therapy_for_inflammatory_bowel_disease.html Abstract Inflammatory bowel disease is a chronic condition of unclear aetiology that can greatly impact on the lives of those affected. Our Drug review discusses the currently available treatments and their properties, followed by sources of further information. Copyright © 2012 Wiley Interface Ltd 2012-02-05T00:00:00Z http://www.prescriber.co.uk/details/journalArticle/1456855/Fingolimod_new_oral_treatment_for_relapsingremitting_MS.html Abstract Fingolimod (Gilenya) is an oral disease‐modifying therapy licensed for relapsingremitting multiple sclerosis (RRMS) in patients with high disease activity despite treatment with an interferon beta. In our New products review, Steve Chaplin presents the clinical data relating to its efficacy and adverse events, and Drs Klaus Schmierer and Rachel Farrell discuss its place in place in the treatment of RRMS. Copyright © 2012... 2012-02-05T00:00:00Z http://www.prescriber.co.uk/details/journalArticle/1456851/Management_of_resistant_Gramnegative_urinary_tract_infections.html Abstract The authors discuss current oral and intravenous treatment options in the management of multiresistant Gram‐negative urinary tract infections in the community. Copyright © 2012 Wiley Interface Ltd 2012-02-05T00:00:00Z http://www.prescriber.co.uk/details/journalArticle/1456853/Prescribing_costs_and_patient_safety_getting_the_balance_right.html 2012-02-05T00:00:00Z http://www.prescriber.co.uk/details/journalArticle/1456859/Neuromodulators_for_pain_management_in_rheumatoid_arthritis.html 2012-02-05T00:00:00Z http://www.prescriber.co.uk/details/journalArticle/1456861/National_Prescribing_Centre_guidance_on_prescribing_specials.html Abstract A special is a bespoke formulation made to meet the needs of an individual patient and requires different considerations to normal licensed products. Here, Steve Chaplin outlines the NPC guidance on prescribing a special. Copyright © 2012 Wiley Interface Ltd 2012-02-05T00:00:00Z http://www.prescriber.co.uk/details/journalArticle/1456863/Pfizer_worlds_largest_researchbased_drug_company.html 2012-02-05T00:00:00Z http://www.prescriber.co.uk/details/journalArticle/1453515/Bydureon_longacting_exenatide_for_onceweekly_injection.html Abstract Bydureon is a long‐acting formulation of exenatide administered as a once‐weekly injection. The authors present the clinical data relating to its efficacy and adverse effects compared with twice‐daily exenatide and other treatments used in type 2 diabetes and discuss its potential role in management. Copyright © 2012 Wiley Interface Ltd 2012-01-05T00:00:00Z http://www.prescriber.co.uk/details/journalArticle/1453517/Concise_guide_to_the_diagnosis_and_management_of_osteoarthritis.html Abstract Osteoarthritis results in joint pain and can reduce participation in daily activities. In our Drug review the authors discuss diagnosis and the available management options, followed by an analysis of the prescription data and sources of further information. Copyright © 2012 Wiley Interface Ltd 2012-01-05T00:00:00Z http://www.prescriber.co.uk/details/journalArticle/1453513/Mirtazapine_versus_other_antidepressive_agents_for_depression.html 2012-01-05T00:00:00Z http://www.prescriber.co.uk/details/journalArticle/1453523/Freezing__salicylic_acid_for_plantar_warts.html 2012-01-05T00:00:00Z http://www.prescriber.co.uk/details/journalArticle/1453527/N__1__Why_People_Matter_in_Medicines__an_RCP_report.html Abstract N = 1. Why People Matter in Medicines was produced by an RCP subgroup tasked with investigating the patient's perspective in medicines usage. Here, Steve Chaplin discusses the findings of the report and its key recommendations. Copyright © 2012 Wiley Interface Ltd 2012-01-05T00:00:00Z http://www.prescriber.co.uk/details/journalArticle/1453519/Gastrooesophageal_reflux_disease_keep_taking_the_tablets.html 2012-01-05T00:00:00Z http://www.prescriber.co.uk/details/journalArticle/1453525/GlaxoSmithKline_a_pharmaceutical_giant_of_many_familiar_parts.html 2012-01-05T00:00:00Z http://www.prescriber.co.uk/details/journalArticle/1453521/Adherence_with_antiosteoporosis_medications_a_primarycare_study.html Abstract The authors describe the results of a study of adherence and persistence in all and new users of anti‐osteoporosis therapies in general practice in Ireland. Copyright © 2012 Wiley Interface Ltd 2012-01-05T00:00:00Z